Table 1

Baseline characteristics of patients with type 2 diabetes and matched controls from the general population

Controls
n=2 173 620
All type 2 diabetes
n=431 579
Men1 170 663 (53.9%)234 556 (54.3%)
Age (years)64.7 (12.6)
n=2 173 620
65.0 (12.7)
n=431 579
Born in Sweden1 902 246 (87.5%)353 441 (82.0%)
Education
 Low770 057 (36.1%)182 183 (43.3%)
 Mid845 048 (39.6%)169 656 (40.4%)
 High520 240 (24.4%)68 508 (16.3%)
Variables in the NDR only
 HbA1c (mmol/mol, IFCC)54.4 (15.0)
n=383 878
 HbA1c (%, NGSP)7.13 (1.37)
n=383 878
 Diabetes duration5.50 (7.06)
n=382 414
 Body mass index (kg/m2)29.7 (5.4)
n=324 054
 Cholesterol (mmol/L)5.10 (1.10)
n=260 743
 HDL cholesterol (mmol/L)1.28 (0.39)
n=229 758
 LDL cholesterol (mmol/L)2.98 (0.96)
n=222 187
 Systolic blood pressure (mm Hg)140.4 (18.2)
n=369 273
 Diastolic blood pressure (mm Hg)78.9 (9.8)
n=369 273
 Smoking53 911 (15.6%)
Registrations in the IPR prior to baseline
 AF (I48)104 426 (4.8%)33 474 (7.8%)
 CHD (I20–I25)77 022 (3.5%)31 853 (7.4%)
 HF (I50)48 208 (2.2%)21 368 (5.0%)
 Valve disease (I05–I09, I34–I36)31 704 (1.5%)8349 (1.9%)
 Stroke (I61–I64)74 137 (3.4%)25 269 (5.9%)
 Cancer (C00–C97)182 757 (8.4%)38 748 (9.0%)
  • AF, atrial fibrillation; CHD, coronary heart disease; HDL, high-density lipoprotein; HF, heart failure; LDL, low-density lipoprotein; NDR, National Diabetes Register.